Calidi Biotherapeutics, Inc.
CLDI
$0.19
$0.015.19%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -46.02% | 96.53% | -50.01% | 10.11% | 405.59% |
| Total Receivables | -- | -- | 0.00% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.61% | 2.12% | -36.74% | 54.01% | 258.33% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -12.69% | -21.87% | 21.63% | 13.25% | 15.28% |
| Total Current Assets | -43.27% | 82.31% | -47.35% | 12.34% | 360.47% |
|
|
|||||
| Total Current Assets | -43.27% | 82.31% | -47.35% | 12.34% | 360.47% |
| Net Property, Plant & Equipment | -13.91% | -12.29% | -4.93% | -9.78% | -9.86% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.43% | 250.00% | -72.22% | -5.26% | -29.95% |
| Total Assets | -36.87% | 50.03% | -37.92% | 6.22% | 113.04% |
|
|
|||||
| Total Accounts Payable | -46.60% | -6.44% | 1.83% | -41.90% | -41.97% |
| Total Accrued Expenses | -16.93% | 12.41% | 9.39% | -40.59% | -16.94% |
| Short-term Debt | -- | -- | -- | -- | 3.27% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -18.97% | -14.64% | -10.64% | -38.24% | 2.82% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -24.22% | -2.99% | -1.35% | -42.86% | -17.99% |
|
|
|||||
| Total Current Liabilities | -24.22% | -2.99% | -1.35% | -42.86% | -17.99% |
| Long-Term Debt | 0.00% | 0.00% | 0.00% | 0.00% | -74.72% |
| Short-term Debt | -- | -- | -- | -- | 3.27% |
| Capital Leases | -46.48% | -31.34% | -26.21% | -16.98% | -14.48% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -42.79% | 95.15% | 18.39% | -32.03% | -27.27% |
| Total Liabilities | -25.37% | -6.10% | -6.31% | -36.43% | -25.77% |
|
|
|||||
| Common Stock & APIC | 0.62% | 7.68% | 0.39% | 8.43% | 14.77% |
| Retained Earnings | -2.95% | -3.89% | -4.51% | -4.10% | -3.48% |
| Treasury Stock & Other | 0.00% | 0.00% | 50.00% | 7.14% | 62.16% |
| Total Common Equity | -45.66% | 292.18% | -74.59% | 352.48% | 114.92% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -45.66% | 292.18% | -74.59% | 352.48% | 114.92% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -10.26% | -12.85% | -17.51% | -10.52% |
| Total Equity | -47.78% | 246.72% | -71.56% | 270.88% | 120.09% |
|
|
|||||